ZA924949B - New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives - Google Patents
New use of benzimidazoline-2-oxo-1-carboxylic acid derivativesInfo
- Publication number
- ZA924949B ZA924949B ZA924949A ZA924949A ZA924949B ZA 924949 B ZA924949 B ZA 924949B ZA 924949 A ZA924949 A ZA 924949A ZA 924949 A ZA924949 A ZA 924949A ZA 924949 B ZA924949 B ZA 924949B
- Authority
- ZA
- South Africa
- Prior art keywords
- benzimidazoline
- oxo
- carboxylic acid
- acid derivatives
- new use
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI911845A IT1250629B (it) | 1991-07-04 | 1991-07-04 | Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA924949B true ZA924949B (en) | 1994-01-03 |
Family
ID=11360276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA924949A ZA924949B (en) | 1991-07-04 | 1992-07-03 | New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0523013B1 (pt) |
| JP (1) | JPH05194216A (pt) |
| KR (1) | KR930001906A (pt) |
| AT (1) | ATE115857T1 (pt) |
| AU (1) | AU658197B2 (pt) |
| CA (1) | CA2072911A1 (pt) |
| DE (1) | DE69200948T2 (pt) |
| DK (1) | DK0523013T3 (pt) |
| GR (1) | GR3015413T3 (pt) |
| HU (2) | HUT61462A (pt) |
| IE (1) | IE922174A1 (pt) |
| IL (1) | IL102381A0 (pt) |
| IT (1) | IT1250629B (pt) |
| MX (1) | MX9203900A (pt) |
| NO (1) | NO922635L (pt) |
| TW (1) | TW202386B (pt) |
| ZA (1) | ZA924949B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2699794B2 (ja) * | 1992-03-12 | 1998-01-19 | 三菱化学株式会社 | チエノ〔３，２−ｂ〕ピリジン誘導体 |
| JPH05310732A (ja) * | 1992-03-12 | 1993-11-22 | Mitsubishi Kasei Corp | シンノリン−３−カルボン酸誘導体 |
| WO2001042224A1 (en) * | 1999-12-09 | 2001-06-14 | Mitsubishi Pharma Corporation | Carboxyamido derivatives |
| US8138177B2 (en) | 2005-03-15 | 2012-03-20 | Pfizer Inc. | Benzimidazolone derivatives as CB2 receptor ligands |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
| DE3751404T2 (de) * | 1986-12-17 | 1995-12-21 | Glaxo Group Ltd | Verwendung von heterocyclischen Verbindungen zur Behandlung von Bewusstseinsstörungen. |
| IT1231413B (it) * | 1987-09-23 | 1991-12-04 | Angeli Inst Spa | Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht |
| US4887422A (en) * | 1988-09-06 | 1989-12-19 | Amsted Industries Incorporated | Rope with fiber core and method of forming same |
-
1991
- 1991-07-04 IT ITMI911845A patent/IT1250629B/it active IP Right Grant
-
1992
- 1992-07-02 EP EP92830346A patent/EP0523013B1/en not_active Expired - Lifetime
- 1992-07-02 CA CA002072911A patent/CA2072911A1/en not_active Abandoned
- 1992-07-02 JP JP4175281A patent/JPH05194216A/ja active Pending
- 1992-07-02 AU AU19381/92A patent/AU658197B2/en not_active Ceased
- 1992-07-02 MX MX9203900A patent/MX9203900A/es unknown
- 1992-07-02 TW TW081105256A patent/TW202386B/zh active
- 1992-07-02 DE DE69200948T patent/DE69200948T2/de not_active Expired - Fee Related
- 1992-07-02 IL IL102381A patent/IL102381A0/xx unknown
- 1992-07-02 DK DK92830346.0T patent/DK0523013T3/da active
- 1992-07-02 AT AT92830346T patent/ATE115857T1/de not_active IP Right Cessation
- 1992-07-03 IE IE217492A patent/IE922174A1/en not_active Application Discontinuation
- 1992-07-03 NO NO92922635A patent/NO922635L/no unknown
- 1992-07-03 KR KR1019920011823A patent/KR930001906A/ko not_active Application Discontinuation
- 1992-07-03 HU HU9202229A patent/HUT61462A/hu unknown
- 1992-07-03 ZA ZA924949A patent/ZA924949B/xx unknown
-
1995
- 1995-03-13 GR GR950400566T patent/GR3015413T3/el unknown
- 1995-06-30 HU HU95P/P00716P patent/HU211855A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT61462A (en) | 1993-01-28 |
| EP0523013A2 (en) | 1993-01-13 |
| IE922174A1 (en) | 1993-01-13 |
| DE69200948D1 (de) | 1995-02-02 |
| IT1250629B (it) | 1995-04-21 |
| ITMI911845A0 (it) | 1991-07-04 |
| ITMI911845A1 (it) | 1993-01-05 |
| HU211855A9 (en) | 1995-12-28 |
| KR930001906A (ko) | 1993-02-22 |
| NO922635L (no) | 1993-01-05 |
| TW202386B (pt) | 1993-03-21 |
| AU658197B2 (en) | 1995-04-06 |
| ATE115857T1 (de) | 1995-01-15 |
| NO922635D0 (no) | 1992-07-03 |
| EP0523013B1 (en) | 1994-12-21 |
| AU1938192A (en) | 1993-01-07 |
| DE69200948T2 (de) | 1995-05-18 |
| EP0523013A3 (en) | 1993-01-27 |
| GR3015413T3 (en) | 1995-06-30 |
| JPH05194216A (ja) | 1993-08-03 |
| MX9203900A (es) | 1993-01-01 |
| IL102381A0 (en) | 1993-01-14 |
| CA2072911A1 (en) | 1993-01-05 |
| DK0523013T3 (da) | 1995-05-08 |
| HU9202229D0 (en) | 1992-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA928170B (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid | |
| AU637086B2 (en) | Use of 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled- release form active in the therapy of organic mental disturbances, and the relative pharmaceutical compositions | |
| NZ240936A (en) | Alkoxy-substituted 1-phenyl-isoquinoline derivative and pharmaceutical compositions | |
| IL104006A (en) | Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them | |
| IL109578A0 (en) | Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
| CY2123B1 (en) | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides drugs containing these compounds and use of such drugs | |
| ZA885192B (en) | Pharmaceutical preparations | |
| NZ218028A (en) | Benzimidazole derivatives and pharmaceutical compositions | |
| IL94819A0 (en) | 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ZA881561B (en) | Substituted pyridine-2,4-dicarboxylic acid derivatives,processes for their preparation,the use thereof and medicaments based on these compounds | |
| GR3015413T3 (en) | Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases. | |
| EP0535250A4 (en) | Novel compounds and use thereof as medicine | |
| IL89335A (en) | 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds | |
| TW218011B (pt) | ||
| IL106289A0 (en) | Phospholipid derivatives, their preparation and pharmaceutical compositions containing them | |
| IL99666A0 (en) | Pharmaceutical compositions for the treatment of diabetes | |
| NZ223333A (en) | 3-phenyl-7h-thiazole (3,2-b (1,2, triazin-7-one derivatives and pharmaceutical compositions | |
| NO163283C (no) | Analogifremgangsm te til fremstilling av terapeutisk aktive n-bicykloheptyl og n-bicykloheptenylimidazoler. |